Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin, Gemcitabine, IFN-alfa, and Hyperthermia in Advanced Cancer
NCT00004063Phase 2Unknown
- Sponsor
- UTHealth Houston
- Start
- Aug 1999
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in solid tumor (advanced stage), sponsored by UTHealth Houston. Primary endpoints: Toxicity, Tumor Response and 5 more. Status: unknown.
02
Drugs
cisplatin
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT00004063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004063.